Safety and efficacy of tenofovir in chronic hepatitis B-related decompensated cirrhosis

AIM: To evaluate the safety and efficacy of tenofovir disoproxil fumarate (TDF) as a first-line therapy in decompensated liver disease. METHODS: We enrolled 174 chronic hepatitis B-related liver cirrhosis patients treated with 300 mg/d TDF at six Korean centers. Of the 174 cirrhosis patients, 57 wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soon Kyu, Song, Myeong Jun, Kim, Seok Hyun, Lee, Byung Seok, Lee, Tae Hee, Kang, Young Woo, Kim, Suk Bae, Song, Il Han, Chae, Hee Bok, Ko, Soon Young, Lee, Jae Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385406/
https://www.ncbi.nlm.nih.gov/pubmed/28428719
http://dx.doi.org/10.3748/wjg.v23.i13.2396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5385406/
https://www.ncbi.nlm.nih.gov/pubmed/28428719
http://dx.doi.org/10.3748/wjg.v23.i13.2396

Ejemplares similares